Literature DB >> 3900924

Predictive testing in cancer chemotherapy. II. In vitro.

P H Slee, A T Van Oosterom, E A De Bruijn.   

Abstract

During the last thirty years several in vitro techniques have been developed to predict sensitivity of individual tumours. When the results of these techniques were correlated with the clinical response in larger groups of patients, the accuracy for predicting resistance was greater than for predicting sensitivity. Amongst the culture techniques the colony-forming assays have received much attention. Research with tumour cell lines and the sound biological basis do support this preference on other techniques. Studies on these assays have come from several independent laboratories, who report comparable results. Improvement of the culture technique and more insight into the in vitro pharmacology is needed, before application on wider scale is justified. Colony-forming culture techniques have not only been propagated for individualized chemotherapy, but also for drug screening. New antitumour agents and analogous can be screened in a short time for their sensitivity in many histologic tumour types.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900924     DOI: 10.1007/bf02097248

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  50 in total

1.  [Experiences with individual cytostatic therapy of malignant tumors following pretherapeutic sensitivity test to cytostatics in vitro (oncobiogram)].

Authors:  S Tanneberger; G Bacigalupo
Journal:  Arch Geschwulstforsch       Date:  1970

2.  "Send this patient's tumor for culture and sensitivity".

Authors:  D D Von Hoff
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

3.  Use of in vitro tests in predictive cancer chemotherapy.

Authors:  A W Hamburger
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

Review 4.  Predictive testing in cancer chemotherapy. I. In vivo.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

5.  A methodological approach to the prediction of anticancer drug effect in humans.

Authors:  W J Durkin; V K Ghanta; C M Balch; D W Davis; R N Hiramoto
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

6.  In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.

Authors:  K M Tveit; O Fodstad; S Olsnes; A Pihl
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

7.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

8.  Methodologic problems in clonogenic assays of spontaneous human tumors.

Authors:  F R MacKintosh; T L Evans; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

9.  Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour.

Authors:  A E Bateman; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

10.  Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.

Authors:  K M Tveit; L Endresen; H E Rugstad; O Fodstad; A Pihl
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

View more
  3 in total

Review 1.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

2.  Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

Authors:  Carl-Olof Hillerdal; Rita Ötvös; Tünde Szatmári; Sulaf Abd Own; Gunnar Hillerdal; Åsa-Lena Dackland; Katalin Dobra; Anders Hjerpe
Journal:  Oncotarget       Date:  2017-09-15

3.  Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells.

Authors:  Syu-Ichi Kanno; Shin Yomogida; Ayako Tomizawa; Hiroyuki Yamazaki; Kazuyo Ukai; Remy E P Mangindaan; Michio Namikoshi; Masaaki Ishikawa
Journal:  Oncol Lett       Date:  2014-06-03       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.